Microba Life Sciences (ASX:MAP) FCF Margin %: -104.44% (As of Dec. 2025)


What is Microba Life Sciences FCF Margin %?

Microba Life Sciences ASX:MAP FCF Margin % is -104.44% as of Dec. 2025. The stock has 6 warning signs investors should review. Among 204 Medical Diagnostics & Research companies, Microba Life Sciences ranks worse than 82.35% on this metric.

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Microba Life Sciences's Free Cash Flow for the six months ended in Dec. 2025 was A$-7.65 Mil. Microba Life Sciences's Revenue for the six months ended in Dec. 2025 was A$7.32 Mil. Therefore, Microba Life Sciences's FCF Margin % for the quarter that ended in Dec. 2025 was -104.44%.

As of today, Microba Life Sciences's current FCF Yield % is -67.95%.

The historical rank and industry rank for Microba Life Sciences's FCF Margin % or its related term are showing as below:

ASX:MAP' s FCF Margin % Range Over the Past 10 Years
Min: -284.7   Med: -213.89   Max: -95.17
Current: -124.5

During the past 4 years, the highest FCF Margin % of Microba Life Sciences was -95.17%. The lowest was -284.70%. And the median was -213.89%.

ASX:MAP's FCF Margin % is ranked worse than
82.35% of 204 companies
in the Medical Diagnostics & Research industry
Industry Median: -1.845 vs ASX:MAP: -124.50

Microba Life Sciences FCF Margin % Related Terms

Microba Life Sciences FCF Margin % Historical Data

* Premium members only.

The historical data trend for Microba Life Sciences's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Microba Life Sciences FCF Margin % Chart

Microba Life Sciences Annual Data
Trend Jun22 Jun23 Jun24 Jun25
FCF Margin %
-262.79 -284.70 -164.98 -95.17

Microba Life Sciences Semi-Annual Data
Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
FCF Margin % Get a 7-Day Free Trial Premium Member Only -406.17 -75.45 -49.47 -143.86 -104.44

ASX:MAP vs TMO, DHR, IDXX: FCF Margin % Comparison

For the Diagnostics & Research subindustry, Microba Life Sciences's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Microba Life Sciences FCF Margin % vs Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Microba Life Sciences's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Microba Life Sciences's FCF Margin % falls into.


Microba Life Sciences FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Microba Life Sciences's FCF Margin for the fiscal year that ended in Jun. 2025 is calculated as

FCF Margin=Free Cash Flow (A: Jun. 2025 )/Revenue (A: Jun. 2025 )
=-14.912/15.669
=-95.17 %

Microba Life Sciences's FCF Margin for the quarter that ended in Dec. 2025 is calculated as

FCF Margin=Free Cash Flow (Q: Dec. 2025 )/Revenue (Q: Dec. 2025 )
=-7.645/7.32
=-104.44 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about FCF Margin % →
What does a FCF Margin % of -104.44% mean?
Microba Life Sciences (ASX:MAP) has a FCF Margin % of -104.44% as of Dec. 2025. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Microba Life Sciences and its competitors. According to the industry distribution chart, Microba Life Sciences ranks #168 out of 204 companies in the Medical Diagnostics & Research industry, placing it in the top 82.4%.
Is Microba Life Sciences' FCF Margin % too high?
Microba Life Sciences' current FCF Margin % is -104.44%. Based on the distribution chart, Microba Life Sciences ranks #168 out of 204 companies in the Medical Diagnostics & Research industry, which is in the bottom quartile relative to peers.
How does Microba Life Sciences' FCF Margin % compare to TMO and DHR?
According to the Medical Diagnostics & Research industry distribution chart, Microba Life Sciences ranks #168 out of 204 companies for FCF Margin %. This places Microba Life Sciences in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Medical Diagnostics & Research company?
A good FCF Margin % depends on the Medical Diagnostics & Research industry context. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Microba Life Sciences and its competitors. Microba Life Sciences's current FCF Margin % is -104.44%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Microba Life Sciences stock overvalued right now?
Based on GuruFocus' analysis, Microba Life Sciences (ASX:MAP) is currently considered Possible Value Trap. The stock's GF Value™ is A$0.25, compared to a current price of A$0.04 — trading 84.4% below its estimated fair value. The current FCF Margin % is -104.44%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Microba Life Sciences (ASX:MAP), the current FCF Margin % is -104.44% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Microba Life Sciences Business Description

Address 324 Queen Street, Level 10, Brisbane, QLD, AUS, 4000
Microba Life Sciences Ltd is a commercial-stage company with technology for measuring the human gut microbiome and engages in providing gut microbiome testing services globally to consumers, clinicians, and researchers. It is also involved in developing new pathology services, therapeutics, and diagnostics based on the human gut microbiome. The company's operating segments are: Testing Services and Supplements, which derive key revenue, and Research and Development. Geographically, the company derives maximum revenue from Australia and the rest from Europe, New Zealand, the United States, Asia, and other regions.